Aion Therapeutic Inc.

AION

CA00905T1021

Pharmaceuticals

Delayed Canadian Securities Exchange Other stock markets 10:35:19 15/05/2024 pm IST			5-day change	1st Jan Change
0.02 ^CAD	0.00%		0.00%	0.00%

22/04	Aion Therapeutic Inc. announced that it expects to receive CAD 0.75 million in funding	CI
02/04	Aion Therapeutic Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2024	CI

Aion Therapeutic Inc. Reports Earnings Results for the Second Quarter Ended October 31, 2020

December 31, 2020 at 03:21 am IST

Aion Therapeutic Inc. announced earnings results for the second quarter ended October 31, 2020. For the second quarter, the company announced net loss was CAD 886,867 compared to net income of CAD 412,202 a year ago. For the half year, net loss was CAD 1.404 million compared to CAD 118,284 a year ago.

Latest news about Aion Therapeutic Inc.

Aion Therapeutic Inc. announced that it expects to receive CAD 0.75 million in funding	22/04	CI
Aion Therapeutic Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2024	02/04	CI
Aion Therapeutic Inc. Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2023	03/01	CI
Aion Therapeutic Inc. completed the acquisition of Toppen Health Inc.	15/12	CI
Aion Therapeutic Inc. entered into a definitive share purchase agreement to acquire Toppen Health Inc. for $4.9 million.	23/23/23	CI
Aion Therapeutic Inc. entered into a definitive share purchase agreement to acquire Toppen Health for $4.9 million.	23/23/23	CI
Aion Therapeutic Inc. announced that it has received CAD 0.6425 million in funding	05/23/05	CI
Aion Therapeutic Inc. Reports Earnings Results for the First Quarter Ended July 31, 2023	29/23/29	CI
Aion Therapeutic Inc. Reports Earnings Results for the Full Year Ended April 30, 2023	28/23/28	CI
Aion Therapeutic Inc. announced that it has received CAD 0.4275 million in funding	14/23/14	CI
Aion Therapeutic Announces Resignation of Rosy Mondin as Director	07/23/07	CI
Aion Therapeutic Inc. announced that it expects to receive CAD 0.5 million in funding	04/23/04	CI
Aion Therapeutic Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2023	04/23/04	CI
Aion Therapeutic Inc. Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2022	30/22/30	CI
Aion Therapeutic Inc. Reports Earnings Results for the First Quarter Ended July 31, 2022	05/22/05	CI
Aion Therapeutic Inc. Reports Earnings Results for the Full Year Ended April 30, 2022	01/22/01	CI
Aion Therapeutic Inc. Auditor Raises 'Going Concern' Doubt	01/22/01	CI
Aion Therapeutic Inc. Announces Management and Board Changes	01/22/01	CI
Aion Therapeutic Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2022	02/22/02	CI
Aion Therapeutic Inc. Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2021	31/21/31	CI
Aion Therapeutic Inc. Reports Earnings Results for the First Quarter Ended July 31, 2021	02/21/02	CI
Aion Therapeutic Inc. Auditor Raises 'Going Concern' Doubt	29/21/29	CI
Aion Therapeutic Inc. Announces to Open Aion International Center for Psychedelic Psychiatry in Jamaica	15/21/15	CI
Aion Therapeutic Inc. announced that it has received CAD 1.487017 million in funding	11/21/11	CI
Apollon and Aion Formulations Kill Breast Cancer Cells Through Multiple Pathways	18/21/18	CI

Chart Aion Therapeutic Inc.

Duration

Period

More charts

Company Profile

Aion Therapeutic Inc. is a Canada-based company, which operates within the health and wellness sector with a diverse portfolio of intellectual property. The Company, through its subsidiary, AI Pharmaceuticals Jamaica Limited, is engaged in research, development and treatment, as well as new therapeutic formulation discovery using data mining and artificial intelligence (AI) techniques. The Company develops healing chemical compounds from medical cannabis in combination with chemical compounds from psychedelic and edible mushrooms to treat conditions, such as cancer, depression, post-traumatic stress disorder (PTSD) and others, as well as opioid and alcohol addiction. The Company is also engaged in offering a water filtration system that incorporates mechanical filtration, membrane filtration, adsorption, silver infection control, ion exchange, and chemical additions into a three-stage water purification solution designed to meet the needs of consumers, business, and industries.

Sector

Pharmaceuticals

Calendar

27/08/2024 - Q4 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Alternative Medicine

	1st Jan change	Capi.
AION THERAPEUTIC INC.	0.00%	6.05M
DONG-E-E-JIAO CO.,LTD.	+45.15%	6.38B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	-14.00%	4.59B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	+9.54%	3.39B
TASLY PHARMACEUTICAL GROUP CO., LTD	-8.99%	3.2B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.	-2.41%	2.52B
HENAN LINGRUI PHARMACEUTICAL CO., LTD.	+50.03%	2B
GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD.	-6.97%	1.7B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD.	-0.31%	1.65B
TIANJIN CHASE SUN PHARMACEUTICAL CO.,LTD	-10.61%	1.58B

Alternative Medicine